Frequency of Lipid-poor Adrenal Adenomas in Magnetic Resonance Imaging Examinations of the Abdomen

Overview

Journal Radiol Bras

Specialty Radiology

Date 2022 Jul 7

PMID 35795608

Authors

Victor Guerra Martins

Cecilia Vidal S Torres

Livia Mara Mermejo

Silvio Tucci Jr

Carlos Augusto Fernandes Molina

Jorge Elias Jr

Valdair Francisco Muglia

Affiliations

Soon will be listed here.

Abstract

Objective: To estimate the frequency of lipid-poor adenomas (LPAs) in magnetic resonance imaging (MRI) examinations.

Materials And Methods: We retrospectively investigated adrenal lesions on MRI examinations performed in a total of 2,014 patients between January 2016 and December 2017. After exclusions, the sample comprised 69 patients with 74 proven adenomas. Two readers (reader 1 and reader 2) evaluated lesion size, laterality, homogeneity, signal drop on out-of-phase (OP) images, and the signal intensity index (SII). An LPA was defined as a lesion with no signal drop on OP images and an SII < 16.5%. For 68 lesions, computed tomography (CT) scans (obtained within one year of the MRI) were also reviewed.

Results: Of the 69 patients evaluated, 42 (60.8%) were women and 27 (39.2%) were men. The mean age was 59.2 ± 14.1 years. Among the 74 confirmed adrenal adenomas evaluated, the mean lesion size was 18.5 ± 7.7 mm (range, 7.0-56.0 mm) for reader 1 and 21.0 ± 8.3 mm (range, 7.0-55.0 mm) for reader 2 ( = 0.055). On the basis of the signal drop in OP MRI sequences, both readers identified five (6.8%) of the 74 lesions as being LPAs. When determined on the basis of the SII, that frequency was three (4.0%) for reader 1 and four (5.4%) for reader 2. On CT, 21 (30.8%) of the 68 lesions evaluated were classified as LPAs.

Conclusion: The prevalence of LPA was significantly lower on MRI than on CT. That prevalence tends to be even lower when the definition of LPA relies on a quantitative analysis rather than on a qualitative (visual) analysis.

Citing Articles

Adrenal Mass Evaluation: Suspicious Radiological Signs of Malignancy.

Grazzini G, Pradella S, De Litteris F, Galluzzo A, Anichini M, Treballi F Cancers (Basel). 2025; 17(5).

PMID: 40075696 PMC: 11899669. DOI: 10.3390/cancers17050849.

References

Park J, Park B, Kim C . Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses. Br J Radiol. 2016; 89(1062):20151018. PMC: 5258164. DOI: 10.1259/bjr.20151018. View

Tsushima Y, Ishizaka H, Matsumoto M . Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology. 1993; 186(3):705-9. DOI: 10.1148/radiology.186.3.8430178. View

Boland G, Lee M, Gazelle G, Halpern E, McNicholas M, Mueller P . Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol. 1998; 171(1):201-4. DOI: 10.2214/ajr.171.1.9648789. View

Heinz-Peer G, Honigschnabl S, Schneider B, Niederle B, Kaserer K, Lechner G . Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR Am J Roentgenol. 1999; 173(1):15-22. DOI: 10.2214/ajr.173.1.10397092. View

Thomas A, Blute Sr M, Seitz C, Habra M, Karam J . Management of the Incidental Adrenal Mass. Eur Urol Focus. 2017; 1(3):223-230. DOI: 10.1016/j.euf.2015.12.006. View

Haider M, Ghai S, Jhaveri K, Lockwood G . Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?. Radiology. 2004; 231(3):711-6. DOI: 10.1148/radiol.2313030676. View

Sancho J, Triponez F, Montet X, Sitges-Serra A . Surgical management of adrenal metastases. Langenbecks Arch Surg. 2011; 397(2):179-94. DOI: 10.1007/s00423-011-0889-1. View

Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S . Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol. 2003; 180(6):1649-57. DOI: 10.2214/ajr.180.6.1801649. View

Outwater E, Siegelman E, Huang A, Birnbaum B . Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology. 1996; 200(3):749-52. DOI: 10.1148/radiology.200.3.8756926. View

10.

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A . Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016; 175(2):G1-G34. DOI: 10.1530/EJE-16-0467. View

11.

Song J, Chaudhry F, Mayo-Smith W . The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008; 190(5):1163-8. DOI: 10.2214/AJR.07.2799. View

12.

Becker-Weidman D, Kalb B, Mittal P, Harri P, Arif-Tiwari H, Farris 3rd A . Differentiation of lipid-poor adrenal adenomas from non-adenomas with magnetic resonance imaging: Utility of dynamic, contrast enhancement and single-shot T2-weighted sequences. Eur J Radiol. 2015; 84(11):2045-51. DOI: 10.1016/j.ejrad.2015.06.032. View

13.

Mayo-Smith W, Lee M, McNicholas M, Hahn P, Boland G, Saini S . Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol. 1995; 165(1):91-5. DOI: 10.2214/ajr.165.1.7785642. View

14.

Israel G, Korobkin M, Wang C, Hecht E, Krinsky G . Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol. 2004; 183(1):215-9. DOI: 10.2214/ajr.183.1.1830215. View

15.

Berland L, Silverman S, Gore R, Mayo-Smith W, Megibow A, Yee J . Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 2010; 7(10):754-73. DOI: 10.1016/j.jacr.2010.06.013. View

16.

Boland G, Dwamena B, Jagtiani Sangwaiya M, Goehler A, Blake M, Hahn P . Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011; 259(1):117-26. DOI: 10.1148/radiol.11100569. View

17.

Welch H, Black W . Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102(9):605-13. DOI: 10.1093/jnci/djq099. View

18.

Platzek I, Sieron D, Plodeck V, Borkowetz A, Laniado M, Hoffmann R . Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis. Eur Radiol. 2018; 29(2):806-817. DOI: 10.1007/s00330-018-5626-5. View

19.

Sebro R, Aslam R, Muglia V, Jane Wang Z, Westphalen A . Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT. Abdom Imaging. 2014; 40(2):318-26. DOI: 10.1007/s00261-014-0208-8. View

20.

Romeo V, Maurea S, Guarino S, Mainenti P, Liuzzi R, Petretta M . The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results. Abdom Radiol (NY). 2017; 43(8):2119-2129. DOI: 10.1007/s00261-017-1429-4. View